Document is current
Any future updates will be listed below
-
Authors
Inui, Tatsuya
Uraya, Yusei
Yokota, Jumpei
Yamashita, Tomoki
Kawai, Kanae
Okada, Kentaro
Ueyama-Toba, Yukiko
Mizuguchi, Hiroyuki https://orcid.org/0000-0003-0594-8178
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and development, AMED (23mk0121258h0001, 23ae0121042h0003)
Health Labour Sciences Research Grant (22KA3005)
JSPS KAKENHI (21K18247, 20K20381, 19J21382)
Platform Project for Supporting Drug Discovery and Life Science Research (JP23ama121054, JP23ama121052)
- License Information
-
More Information
Article History
Received: 21 December 2023
Accepted: 23 February 2024
First Online: 29 February 2024
Ethics approval and consent to participate
: All protocols were approved by the ethics committee of Osaka University (approval number: 28-3-3, approval date: 2021-04-03, name of approval project: Fundamental research for the development of in vitro drug safety and efficacy evaluation systems using various human-derived stem cells) and were performed according to the committee’s guidelines.
: C Not applicable.
: The authors declare that they have no competing interests.
